Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

SciClone acquires rights in U.S. and Canada to RP-101

May 2, 2007

Kyowa Hakko Kogyo licenses Japanese and Asian rights to ARQ-197

May 2, 2007

Novel Amgen c-Met inhibitors reported to be active against multiple mutations

April 30, 2007

CHMP hands down negative opinion on Genasense for melanoma

April 30, 2007

Vascular disrupting activity of MPC-6827 alone or in combination with carboplatin

April 30, 2007

New somatostatin receptor ligand shows antitumor activity in vivo

April 30, 2007

Novel c-Met inhibitor presented at the AACR meeting

April 30, 2007

Preclinical profile of the c-Met inhibitor ARQ-197 reported by ArQule

April 30, 2007

Targeting the sodium pump alpha1 subunit shows promising results in NSCLC

April 30, 2007

Novel therapeutic strategies for cancer covered in recent patent literature

April 30, 2007

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 3, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...